
Ocular Therapeutix (OCUL)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Ocular Therapeutix (OCUL) Stock
Start investing in Ocular Therapeutix (OCUL)
About Ocular Therapeutix (OCUL)
Market cap | $1.51B |
Yesterday's volume | 3.24M |
Revenue (TTM) | $59.65M |
Avg. daily volume | 2.15M |
EBITDA (TTM) | -$200.23M |
Open | $9.19 |
Price / earnings ratio | -8.24x |
Yesterday's range | $9.04 - $9.6 |
Debt / equity | 28.66x |
52 week range | $5.79 - $11.78 |
5 year debt / equity | 83.93x |
Beta (LTM) | 1.47x |
Interest coverage | -12.65x |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 10.22x |
Ex-dividend date | — |
Next earnings | Aug 6, 2025 |
Dividend payable date | — |
Ocular Therapeutix Stock Rating
Ocular Therapeutix Stock News
View all



Frequently Asked Questions (FAQ)
How to buy OCUL stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in OCUL stock
Navigate to the Explore page. Then, type OCUL into the search bar. When you see OCUL stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased OCUL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Ocular Therapeutix Stock Earnings
The value each OCUL share was expected to gain vs. the value that each OCUL share actually gained.
Ocular Therapeutix (OCUL) reported Q1 2025 earnings per share (EPS) of -$0.38, missing estimates of -$0.28 by 35.71%. In the same quarter last year, Ocular Therapeutix's earnings per share (EPS) was -$0.28. Ocular Therapeutix is expected to release next earnings on 08/06/2025, with an earnings per share (EPS) estimate of -$0.35.